Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pionyr Immunotherapeutics IncfiledCriticalPionyr Immunotherapeutics Inc
Publication of AR118028A1publicationCriticalpatent/AR118028A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
En la presente se proporcionan anticuerpos anti-TREM1 y métodos relacionados para crear y usar anticuerpos anti-TREM1. También se proporcionan métodos y composiciones para mejorar una respuesta inmunitaria y/o para el tratamiento de una condición relacionada con lo inmunitario en una persona, p. ej., cáncer, que comprende la eliminación, la incapacitación o la reducción de células mieloides no estimuladoras mediante un anticuerpo anti-TREM1 o un fragmento de unión a antígeno de este.Provided herein are anti-TREM1 antibodies and related methods for creating and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and / or for treating an immune-related condition in a person, e.g. eg, cancer, which comprises the elimination, incapacitation or reduction of non-stimulatory myeloid cells by an anti-TREM1 antibody or an antigen-binding fragment thereof.
ARP200100332A2019-02-062020-02-06
ANTI-TREM1 ANTIBODIES AND RELATED METHODS
AR118028A1
(en)